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ANNOUNCEMENT 
T he First J o in t Meeting of the Japanese and Canadian Societies for Inves tigative D ermatology 
will be held M ay 31. June 1 and 2, 1996 at the Whistle r, Bristish Columbia , C anada. 
T he major theme will be "What can we learn and expect fi·om our studies of basic biology 
and molecu lar biol ogy of the skin? Current con cepts and application to new diagnosis and 
treatm ent approaches of skin diseases." 
The meeting is organized by the Canadian Society fo r Invescigacive Dermatology and 
Japanese Soci.ety for Investigative Dermatology. 
T here will be two pl enary sess ions, one clinica lly-oriented research small-group session, 
poster re views, and three workshops; Workshop 1 will be "Melanin Pigmentation and 
M alignant Melanoma," workshop 2 wi ll be "Genetic Analysis and G ene Therapy," workshop 
3 will be "Cytokines and dendricic cells," and sess ion 1 will be "Clinically-Oriented 
Resea rch ." 
For more information , abstract and registratio n forms please contac t JSID /CSID Adminis-
tratio n o fl:i ce. University of Alberta, D ermatology & Cutaneous Sciences Division, 260G 
H eri tage M edi ca l Research Centre, Edmonton , AD T6G 2S2 Canada; phone (403) 492-1875, 
fax (403) 492-7715 . 
